SCHEMBL3284353

SCHEMBL3284353

COC(=O)c1cc(N2CCOCC2)cc(N2CCC(NC(=O)OC(C)(C)C)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4D Q6B0I6 2/20 0.44
CKS1B P61024 1/20 0.42
SKP1 P63208 1/20 0.42
SKP2 Q13309 1/20 0.42
SUV39H2 Q9H5I1 2/20 0.42
GAA P10253 1/20 0.42
DRD2 P14416 1/20 0.41
DRD3 P35462 1/20 0.41
BTK Q06187 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
CTSK P43235 2/20 0.40
GPR119 Q8TDV5 1/20 0.40
USP30 Q70CQ3 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
NAMPT P43490 1/20 0.39
KCNA3 P22001 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3281872 0.88 DRD2 (0.44) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL3282053 0.86 CKS1B (0.45) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL5203538 0.84 ALDH1A1 (0.51) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL9181830 0.83 GPR119 (0.45) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL3282162 0.82 KDM4D (0.51) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL3280488 0.81 CKS1B (0.48) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL3281315 0.81 DRD2 (0.40) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL5223324 0.80 CKS1B (0.50) CKS1BSKP1SKP2SUV39H2DRD2
SCHEMBL3288523 0.80 KDM4D (0.41) KDM4DCKS1BSKP1SKP2SUV39H2
SCHEMBL24736633 0.79 CKS1B (0.44) KDM4DCKS1BSKP1SKP2SUV39H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1882568-B Pyrrol derivatives with antibacterial activity ASTRAZENECA AB 2012-03-28 CN disclosed
US-7709503-B2 Pyrrol derivatives with antibacterial activity ASTRAZENECA AB (SE) 2010-05-04 US disclosed
EP-1664025-B1 PYRROL DERIVATIVES WITH ANTIBACTERIAL ACTIVITY ASTRAZENECA AB (SE) 2007-09-19 EP disclosed
CN-1882568-A Pyrrol derivatives with antibacterial activity ASTRAZENECA AB (SE) 2006-12-20 CN disclosed
US-20060223801-A1 Pyrrol derivatives with antibacterial activity ASTRAZENECA AB (SE) 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223801-A1 Pyrrol derivatives with antibacterial activity PEF1, PEPD, PELP1 KDM4D 3881/4885CKS1B 3848/4885SKP1 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.